Last reviewed · How we verify
Radiolabelled Diclofenac tablet C
Radiolabelled Diclofenac tablet C is a Small molecule drug developed by BDD Pharma Ltd. It is currently in Phase 1 development. Also known as: Delayed release diclofenac sodium tablet.
At a glance
| Generic name | Radiolabelled Diclofenac tablet C |
|---|---|
| Also known as | Delayed release diclofenac sodium tablet |
| Sponsor | BDD Pharma Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Radiolabelled Diclofenac tablet C CI brief — competitive landscape report
- Radiolabelled Diclofenac tablet C updates RSS · CI watch RSS
- BDD Pharma Ltd portfolio CI
Frequently asked questions about Radiolabelled Diclofenac tablet C
What is Radiolabelled Diclofenac tablet C?
Radiolabelled Diclofenac tablet C is a Small molecule drug developed by BDD Pharma Ltd.
Who makes Radiolabelled Diclofenac tablet C?
Radiolabelled Diclofenac tablet C is developed by BDD Pharma Ltd (see full BDD Pharma Ltd pipeline at /company/bdd-pharma-ltd).
Is Radiolabelled Diclofenac tablet C also known as anything else?
Radiolabelled Diclofenac tablet C is also known as Delayed release diclofenac sodium tablet.
What development phase is Radiolabelled Diclofenac tablet C in?
Radiolabelled Diclofenac tablet C is in Phase 1.
Related
- Manufacturer: BDD Pharma Ltd — full pipeline
- Also known as: Delayed release diclofenac sodium tablet
- Compare: Radiolabelled Diclofenac tablet C vs similar drugs
- Pricing: Radiolabelled Diclofenac tablet C cost, discount & access